{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T20:25:59Z","timestamp":1663791959643},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T00:00:00Z","timestamp":1591056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T00:00:00Z","timestamp":1591056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Bonn"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chirurg"],"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:sec>\n                <jats:title>Hintergrund<\/jats:title>\n                <jats:p>Wenngleich in Bezug auf Therapie und Krankheitsverst\u00e4ndnis bei der prim\u00e4r sklerosierenden Cholangitis (PSC) in den vergangenen Jahren erhebliche Fortschritte zu beobachten sind, so ist bei Karzinom und \u201eend-stage liver disease\u201c (ELD) eine Lebertransplantation (LTX) meist die einzige Chance auf Heilung. In seltenen F\u00e4llen ist eine Leberteilresektion (LR) zur kurativen Therapie des PSC-assoziierten Gallengangskarzinoms (CCC) m\u00f6glich. Diese Operationen stellen f\u00fcr PSC-Patienten eine zus\u00e4tzliche Belastung dar.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Ziel<\/jats:title>\n                <jats:p>Auch aufgrund der Seltenheit der Erkrankung sind detaillierte Studien zur hepatopankreatikobili\u00e4ren (HPB-)Chirurgie der PSC rar. Ziel dieser Arbeit ist es, die HPB-chirurgische Indikation und Prognose von PSC Patienten zu untersuchen.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Patienten und Methoden<\/jats:title>\n                <jats:p>Es erfolgte eine monozentrische, retrospektive Kohortenstudie von 1990 bis 2020. In dieser wurden Patienten mit PSC eingeschlossen und in Bezug auf operationsassoziierte Faktoren sowie deren Prognose untersucht.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Ergebnisse<\/jats:title>\n                <jats:p>Bei 62\u00a0Patienten (36\u202f%) war eine PSC-bedingte, gr\u00f6\u00dfere hepatopankreatikobili\u00e4re Operation oder Exploration notwendig. Diese Patienten litten signifikant h\u00e4ufiger an einer chronisch entz\u00fcndlichen Darmerkrankung (<jats:italic>p<\/jats:italic>\u202f&lt;\u20090,019). Eine LTX erfolgte bei 46 dieser Patienten (73\u202f%) aufgrund eines ELD. Eine LR erfolgte bei 8\u00a0Patienten (11\u202f%). 9\u00a0Patienten wurden lediglich explorativ laparotomiert. Das \u00dcberleben in der LTX-Subgruppe war signifikant l\u00e4nger als nach LR bzw. explorativer Laparotomie (258 Monate; 95\u202f%-Konfidenzintervall [CI] 210\u2013306 vs. 88; 95\u202f%-CI 16\u2013161 vs. 13; 95\u202f%-CI 3\u201323; <jats:italic>p<\/jats:italic>\u202f&lt;\u20090,05).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Diskussion<\/jats:title>\n                <jats:p>Ein gro\u00dfer Anteil der Patienten mit PSC muss aufgrund der Erkrankung operiert werden mit erheblichem Risiko f\u00fcr Morbidit\u00e4t und Mortalit\u00e4t. Bei fehlenden kurativen Therapieoptionen w\u00e4ren Fr\u00fchdiagnosestrategien zu begr\u00fc\u00dfen, um das PSC-CCC im Fr\u00fchstadium erkennen und behandeln zu k\u00f6nnen.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00104-020-01197-5","type":"journal-article","created":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T15:07:47Z","timestamp":1591110467000},"page":"148-157","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Chirurgische Therapie der prim\u00e4r sklerosierenden Cholangitis"],"prefix":"10.1007","volume":"92","author":[{"given":"Vittorio","family":"Branchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias J.","family":"Weism\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taotao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas","family":"Henn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Semaan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim R.","family":"Glowka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Gonzalez-Carmona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Strassburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg C.","family":"Kalff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steffen","family":"Manekeller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanno","family":"Matthaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,2]]},"reference":[{"key":"1197_CR1","doi-asserted-by":"publisher","first-page":"S642","DOI":"10.1016\/s0168-8278(16)01197-1","volume":"64","author":"R Alberts","year":"2016","unstructured":"Alberts\u00a0R, de Vries\u00a0EM, Alexander\u00a0G, Alvaro\u00a0D, Bergquist\u00a0A, Beuers\u00a0U, Bj\u00f6rnsson\u00a0E, Boberg\u00a0KM, Bowlus\u00a0CL, Chapman\u00a0RW, Chazouill\u00e9res\u00a0O, Cheung\u00a0A, Dalekos\u00a0G, Eksteen\u00a0B, Eaton\u00a0JE, Ellinghaus\u00a0D, F\u00e4rkkil\u00e4\u00a0M, Festen\u00a0EA, Floreani\u00a0A, Folseraas\u00a0T, Goode\u00a0E, Gotthardt\u00a0DN, Hirschfield\u00a0GM, van Hoek\u00a0B, Hohenester\u00a0S, Holm\u00a0K, Hov\u00a0JR, Imhann\u00a0F, Invernizzi\u00a0P, Jiang\u00a0X, Juran\u00a0BD, Lazaridis\u00a0KN, Leppa\u00a0V, Liu\u00a0JZ, L\u00f6fberg\u00a0J, Manns\u00a0MP, Marschall\u00a0H\u2011U, Marzioni\u00a0M, Mason\u00a0AL, Melum\u00a0E, M\u00fcller\u00a0T, Milkiewicz\u00a0P, Pares\u00a0A, Pelkonen\u00a0V, Pinzani\u00a0M, Rombouts\u00a0K, Rupp\u00a0C, Rushbrook\u00a0SM, Rust\u00a0C, Sampaziotis\u00a0F, Sandford\u00a0RN, Schramm\u00a0C, Schreiber\u00a0S, Schrumpf\u00a0E, Silverberg\u00a0M, Srivastava\u00a0B, Sterneck\u00a0M, Teufel\u00a0A, Tittmann\u00a0L, Vallier\u00a0L, Vila\u00a0AV, de Vries\u00a0BA, Weism\u00fcller\u00a0TJ, Wijmenga\u00a0C, Zachou\u00a0K, Franke\u00a0A, Anderson\u00a0CA, Karlsen\u00a0TH, Ponsioen\u00a0CY, Weersma\u00a0K (2016) Genotype-phenotype analysis across 130,422 genetic variants identifies Rspo3 as the first genome-wide significant modifier gene in primary sclerosing cholangitis. J\u00a0Hepatol 64:S642\u2013S643. https:\/\/doi.org\/10.1016\/s0168-8278(16)01197-1","journal-title":"J Hepatol"},{"key":"1197_CR2","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1477-2574.2010.00268.x","volume":"13","author":"M Aljiffry","year":"2011","unstructured":"Aljiffry\u00a0M, Renfrew\u00a0PD, Walsh\u00a0MJ, Laryea\u00a0M, Molinari\u00a0M (2011) Analytical review of diagnosis and treatment strategies for dominant bile duct strictures in patients with primary sclerosing cholangitis. HPB 13:79\u201390. https:\/\/doi.org\/10.1111\/j.1477-2574.2010.00268.x","journal-title":"HPB"},{"key":"1197_CR3","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1046\/j.1440-1746.2002.02835.x","volume":"17","author":"TL Ang","year":"2002","unstructured":"Ang\u00a0TL, Fock\u00a0KM, Ng\u00a0TM, Teo\u00a0EK, Chua\u00a0TS, Tan\u00a0JYL (2002) Clinical profile of primary sclerosing cholangitis in Singapore. J\u00a0Gastroenterol Hepatol 17:908\u2013913. https:\/\/doi.org\/10.1046\/j.1440-1746.2002.02835.x","journal-title":"J Gastroenterol Hepatol"},{"key":"1197_CR4","doi-asserted-by":"publisher","first-page":"4794","DOI":"10.3748\/wjg.v22.i20.4794","volume":"22","author":"JE Axelrad","year":"2016","unstructured":"Axelrad\u00a0JE, Lichtiger\u00a0S, Yajnik\u00a0V (2016) Inflammatory bowel disease and cancer: The role of inflammation, immunosuppression, and cancer treatment. World J Gastroenterol 22:4794. https:\/\/doi.org\/10.3748\/wjg.v22.i20.4794","journal-title":"World J Gastroenterol"},{"key":"1197_CR5","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1002\/hep.26565","volume":"58","author":"K Boonstra","year":"2013","unstructured":"Boonstra\u00a0K, Weersma\u00a0RK, van Erpecum\u00a0KJ, Rauws\u00a0EA, Spanier\u00a0BWM, Poen\u00a0AC, van Nieuwkerk\u00a0KM, Drenth\u00a0JP, Witteman\u00a0BJ, Tuynman\u00a0HA, Naber\u00a0AH, Kingma\u00a0PJ, van Buuren\u00a0HR, van Hoek\u00a0B, Vleggaar\u00a0FP, van Geloven\u00a0N, Beuers\u00a0U, Ponsioen\u00a0CY (2013) Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis. Hepatology 58:2045\u20132055. https:\/\/doi.org\/10.1002\/hep.26565","journal-title":"Hepatology"},{"key":"1197_CR6","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1111\/j.1600-6143.2011.03969.x","volume":"12","author":"D Goldberg","year":"2012","unstructured":"Goldberg\u00a0D, Bittermann\u00a0T, Makar\u00a0G (2012) Lack of standardization in exception points for patients with primary sclerosing cholangitis and bacterial cholangitis. Am J Transplant 12:1603\u20131609. https:\/\/doi.org\/10.1111\/j.1600-6143.2011.03969.x","journal-title":"Am J Transplant"},{"key":"1197_CR7","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1111\/liv.14180","volume":"39","author":"MM Grimsrud","year":"2019","unstructured":"Grimsrud\u00a0MM, Folseraas\u00a0T (2019) Pathogenesis, diagnosis and treatment of premalignant and malignant stages of cholangiocarcinoma in primary sclerosing cholangitis. Liver Int 39:2230\u20132237. https:\/\/doi.org\/10.1111\/liv.14180","journal-title":"Liver Int"},{"key":"1197_CR8","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1093\/ecco-jcc\/jjz094","volume":"13","author":"I Guerra","year":"2019","unstructured":"Guerra\u00a0I, Bujanda\u00a0L, Castro\u00a0J, Merino\u00a0O, Tosca\u00a0J, Camps\u00a0B, Guti\u00e9rrez\u00a0A, Gordillo \u00c1balos\u00a0J, de Castro\u00a0L, Iborra\u00a0M, Carbajo\u00a0AY, Taxonera\u00a0C, Rodr\u00edguez-Lago\u00a0I, Mesonero\u00a0F, de Francisco\u00a0R, G\u00f3mez-G\u00f3mez\u00a0GJ, Chaparro\u00a0M, Tardillo\u00a0CA, Rivero\u00a0M, Algaba\u00a0A, Mart\u00edn Arranz\u00a0E, Ca\u00f1ete\u00a0F, Vicente\u00a0R, Sicilia\u00a0B, Antol\u00edn\u00a0B, Prieto\u00a0V, M\u00e1rquez\u00a0L, Ben\u00edtez\u00a0JM, Camo\u00a0P, Piqueras\u00a0M, Gargallo\u00a0CJ, Hinojosa\u00a0E, Huguet\u00a0JM, P\u00e9rez Calle\u00a0JL, Van Domselaar\u00a0M, Rodriguez\u00a0C, Calvet\u00a0X, Mu\u00f1oz-Villafranca\u00a0C, Garc\u00eda-Sepulcre\u00a0MF, Munoz-Garrido\u00a0P, Fern\u00e1ndez-Clotet\u00a0A, G\u00f3mez\u00a0IL, Hern\u00e1ndez\u00a0S, Guardiola\u00a0J, Sempere\u00a0L, Gonz\u00e1lez Mu\u00f1oza\u00a0C, Hern\u00e1ndez\u00a0V, Beltr\u00e1n\u00a0B, Barrio\u00a0J, Alba\u00a0C, Moraleja\u00a0I, L\u00f3pez-Sanrom\u00e1n\u00a0A, Riestra\u00a0S, Mart\u00ednez Montiel\u00a0P, Garre\u00a0A, Arranz\u00a0L, Garc\u00eda\u00a0MJ, Mart\u00edn Arranz\u00a0MD, Corsino\u00a0P, Arias\u00a0L, Fern\u00e1ndez-Salazar\u00a0L, Fern\u00e1ndez-Pordomingo\u00a0A, Andreu\u00a0M, Iglesias\u00a0E, Ber\u00a0Y, Mena\u00a0R, Arroyo Villarino\u00a0MT, Mora\u00a0M, Ruiz\u00a0L, L\u00f3pez-Serrano\u00a0P, Blazquez\u00a0I, Villoria\u00a0A, Fern\u00e1ndez\u00a0M, Bermejo\u00a0F, Banales\u00a0JM, Dom\u00e8nech\u00a0E, Gisbert\u00a0JP (2019) Clinical characteristics, associated malignancies and management of primary sclerosing cholangitis in inflammatory bowel disease patients: a multicentre retrospective cohort study. J\u00a0Crohns Colitis 13:1492\u20131500. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjz094","journal-title":"J Crohns Colitis"},{"key":"1197_CR9","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/lt.24350","volume":"22","author":"T Hildebrand","year":"2016","unstructured":"Hildebrand\u00a0T, Pannicke\u00a0N, Dechene\u00a0A, Gotthardt\u00a0DN, Kirchner\u00a0G, Reiter\u00a0FP, Sterneck\u00a0M, Herzer\u00a0K, Lenzen\u00a0H, Rupp\u00a0C, Barg-Hock\u00a0H, De Leuw\u00a0P, Teufel\u00a0A, Zimmer\u00a0V, Lammert\u00a0F, Sarrazin\u00a0C, Spengler\u00a0U, Rust\u00a0C, Manns\u00a0MP, Strassburg\u00a0CP, Schramm\u00a0C, Weism\u00fcller\u00a0TJ (2016) Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis: A retrospective multicenter analysis. Liver Transpl 22:42\u201352. https:\/\/doi.org\/10.1002\/lt.24350","journal-title":"Liver Transpl"},{"key":"1197_CR10","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/S0140-6736(13)60096-3","volume":"382","author":"GM Hirschfield","year":"2013","unstructured":"Hirschfield\u00a0GM, Karlsen\u00a0TH, Lindor\u00a0KD, Adams\u00a0DH (2013) Primary sclerosing cholangitis. Lancet 382:1587\u20131599. https:\/\/doi.org\/10.1016\/S0140-6736(13)60096-3","journal-title":"Lancet"},{"key":"1197_CR11","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s11938-005-0004-1","volume":"8","author":"CS Huang","year":"2005","unstructured":"Huang\u00a0CS, Lichtenstein\u00a0DR (2005) Treatment of biliary problems in inflammatory bowel disease. Curr Treat Options Gastroenterol 8:117\u2013126. https:\/\/doi.org\/10.1007\/s11938-005-0004-1","journal-title":"Curr Treat Options Gastroenterol"},{"key":"1197_CR12","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nrgastro.2016.154","volume":"14","author":"X Jiang","year":"2017","unstructured":"Jiang\u00a0X, Karlsen\u00a0TH (2017) Genetics of primary sclerosing cholangitis and pathophysiological implications. Nat Rev Gastroenterol Hepatol 14:279\u2013295. https:\/\/doi.org\/10.1038\/nrgastro.2016.154","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1197_CR13","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1007\/s11605-010-1256-1","volume":"14","author":"R Kashyap","year":"2010","unstructured":"Kashyap\u00a0R, Safadjou\u00a0S, Chen\u00a0R, Mantry\u00a0P, Sharma\u00a0R, Patil\u00a0V, Maloo\u00a0M, Ryan\u00a0C, Marroquin\u00a0C, Barry\u00a0C, Ramaraju\u00a0G, Maliakkal\u00a0B, Orloff\u00a0M (2010) Living donor and deceased donor liver transplantation for autoimmune and cholestatic liver diseases\u2014an analysis of the UNOS database. J\u00a0Gastrointest Surg 14:1362\u20131369. https:\/\/doi.org\/10.1007\/s11605-010-1256-1","journal-title":"J Gastrointest Surg"},{"key":"1197_CR14","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1016\/j.humpath.2014.05.008","volume":"45","author":"SE Kerr","year":"2014","unstructured":"Kerr\u00a0SE, Barr Fritcher\u00a0EG, Campion\u00a0MB, Voss\u00a0JS, Kipp\u00a0BR, Halling\u00a0KC, Lewis\u00a0JT (2014) Biliary dysplasia in primary sclerosing cholangitis harbors cytogenetic abnormalities similar to cholangiocarcinoma. Hum Pathol 45:1797\u20131804. https:\/\/doi.org\/10.1016\/j.humpath.2014.05.008","journal-title":"Hum Pathol"},{"key":"1197_CR15","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1136\/gut.41.4.522","volume":"41","author":"D Kornfeld","year":"1997","unstructured":"Kornfeld\u00a0D, Ekbom\u00a0A, Ihre\u00a0T (1997) Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis? A population based study. Gut 41:522\u2013525. https:\/\/doi.org\/10.1136\/gut.41.4.522","journal-title":"Gut"},{"key":"1197_CR16","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.cgh.2012.12.032","volume":"11","author":"L Lindstr\u00f6m","year":"2013","unstructured":"Lindstr\u00f6m\u00a0L, Hultcrantz\u00a0R, Boberg\u00a0KM, Friis-Liby\u00a0I, Bergquist\u00a0A (2013) Association between reduced levels of alkaline phosphatase and survival times of patients with primary sclerosing cholangitis. Clin Gastroenterol Hepatol 11:841\u2013846. https:\/\/doi.org\/10.1016\/j.cgh.2012.12.032","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1197_CR17","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1007\/s10620-014-3152-0","volume":"59","author":"R Liu","year":"2014","unstructured":"Liu\u00a0R, Cox\u00a0K, Guthery\u00a0SL, Book\u00a0L, Witt\u00a0B, Chadwick\u00a0B, Adler\u00a0DG (2014) Cholangiocarcinoma and high-grade dysplasia in young patients with primary sclerosing cholangitis. Dig Dis Sci 59:2320\u20132324. https:\/\/doi.org\/10.1007\/s10620-014-3152-0","journal-title":"Dig Dis Sci"},{"key":"1197_CR18","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1136\/gut.2004.046615","volume":"54","author":"EV Loftus","year":"2005","unstructured":"Loftus\u00a0EV, Harewood\u00a0GC, Loftus\u00a0CG, Tremaine\u00a0WJ, Harmsen\u00a0WS, Zinsmeister\u00a0AR, Jewell\u00a0DA, Sandborn\u00a0WJ (2005) PSC-IBD: A unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut 54:91\u201396. https:\/\/doi.org\/10.1136\/gut.2004.046615","journal-title":"Gut"},{"key":"1197_CR19","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/j.1600-6143.2004.00703.x","volume":"5","author":"RM Merion","year":"2005","unstructured":"Merion\u00a0RM, Schaubel\u00a0DE, Dykstra\u00a0DM, Freeman\u00a0RB, Port\u00a0FK, Wolfe\u00a0RA (2005) The survival benefit of liver transplantation. Am J Transplant 5:307\u2013313. https:\/\/doi.org\/10.1111\/j.1600-6143.2004.00703.x","journal-title":"Am J Transplant"},{"key":"1197_CR20","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1136\/gutjnl-2016-313598","volume":"67","author":"T M\u00fcller","year":"2018","unstructured":"M\u00fcller\u00a0T, Alberts\u00a0R, De Vries\u00a0EMG, Goode\u00a0EC, Jiang\u00a0X, Sampaziotis\u00a0F, Rombouts\u00a0K, B\u00f6ttcher\u00a0K, Folseraas\u00a0T, Weism\u00fcller\u00a0TJ, Mason\u00a0AL, Wang\u00a0W, Alexander\u00a0G, Alvaro\u00a0D, Bergquist\u00a0A, Bj\u00f6rkstr\u00f6m\u00a0NK, Beuers\u00a0U, Bj\u00f6rnsson\u00a0E, Boberg\u00a0KM, Bowlus\u00a0CL, Bragazzi\u00a0MC, Carbone\u00a0M, Chazouill\u00e8res\u00a0O, Cheung\u00a0A, Dalekos\u00a0G, Eaton\u00a0J, Eksteen\u00a0B, Ellinghaus\u00a0D, F\u00e4rkkil\u00e4\u00a0M, Festen\u00a0EAM, Floreani\u00a0A, Franceschet\u00a0I, Gotthardt\u00a0DN, Hirschfield\u00a0GM, Van Hoek\u00a0B, Holm\u00a0K, Hohenester\u00a0S, Hov\u00a0JR, Imhann\u00a0F, Invernizzi\u00a0P, Juran\u00a0BD, Lenzen\u00a0H, Lieb\u00a0W, Liu\u00a0JZ, Marschall\u00a0HU, Marzioni\u00a0M, Melum\u00a0E, Milkiewicz\u00a0P, Pares\u00a0A, Rupp\u00a0C, Rust\u00a0C, Sandford\u00a0RN, Schramm\u00a0C, Schreiber\u00a0S, Schrumpf\u00a0E, Silverberg\u00a0MS, Srivastava\u00a0B, Sterneck\u00a0M, Teufel\u00a0A, Vallier\u00a0L, Verheij\u00a0J, Vila\u00a0AV, De Vries\u00a0B, Zachou\u00a0K, Chapman\u00a0RW, Manns\u00a0MP, Pinzani\u00a0M, Rushbrook\u00a0SM, Lazaridis\u00a0KN, Franke\u00a0A, Anderson\u00a0CA, Karlsen\u00a0TH, Ponsioen\u00a0CY, Weersma\u00a0RK (2018) Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis. Gut 67:1517\u20131524. https:\/\/doi.org\/10.1136\/gutjnl-2016-313598","journal-title":"Gut"},{"key":"1197_CR21","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.3748\/wjg.v20.i12.3245","volume":"20","author":"T Nakazawa","year":"2014","unstructured":"Nakazawa\u00a0T, Naitoh\u00a0I, Hayashi\u00a0K, Sano\u00a0H, Miyabe\u00a0K, Shimizu\u00a0S, Joh\u00a0T (2014) Inflammatory bowel disease of primary sclerosing cholangitis: A distinct entity? World J Gastroenterol 20:3245\u20133254. https:\/\/doi.org\/10.3748\/wjg.v20.i12.3245","journal-title":"World J Gastroenterol"},{"key":"1197_CR22","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1136\/gutjnl-2018-316801","volume":"68","author":"C Rupp","year":"2019","unstructured":"Rupp\u00a0C, Hippchen\u00a0T, Bruckner\u00a0T, Kl\u00f6ters-Plachky\u00a0P, Schaible\u00a0A, Koschny\u00a0R, Stiehl\u00a0A, Gotthardt\u00a0DN, Sauer\u00a0P (2019) Effect of scheduled endoscopic dilatation of dominant strictures on outcome in patients with primary sclerosing cholangitis. Gut 68:2170\u20132178. https:\/\/doi.org\/10.1136\/gutjnl-2018-316801","journal-title":"Gut"},{"key":"1197_CR23","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.jhep.2007.11.019","volume":"48","author":"K Said","year":"2008","unstructured":"Said\u00a0K, Glaumann\u00a0H, Bergquist\u00a0A (2008) Gallbladder disease in patients with primary sclerosing cholangitis. J\u00a0Hepatol 48:598\u2013605. https:\/\/doi.org\/10.1016\/j.jhep.2007.11.019","journal-title":"J Hepatol"},{"key":"1197_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1756284818787400","volume":"11","author":"P Santiago","year":"2018","unstructured":"Santiago\u00a0P, Scheinberg\u00a0AR, Levy\u00a0C (2018) Cholestatic liver diseases: new targets, new therapies. Therap Adv Gastroenterol 11:1\u201315","journal-title":"Therap Adv Gastroenterol"},{"key":"1197_CR25","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1067\/mge.2002.125367","volume":"56","author":"RM Soetikno","year":"2002","unstructured":"Soetikno\u00a0RM, Lin\u00a0OS, Heidenreich\u00a0PA, Young\u00a0HS, Blackstone\u00a0MO (2002) Increased risk of colorectal neoplasia in patiets with primary sclerosing cholangitis and ulcerative colitis: A meta-analysis. Gastrointest Endosc 56:48\u201354. https:\/\/doi.org\/10.1067\/mge.2002.125367","journal-title":"Gastrointest Endosc"},{"key":"1197_CR26","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s12016-019-08764-7","volume":"58","author":"J Song","year":"2020","unstructured":"Song\u00a0J, Li\u00a0Y, Bowlus\u00a0CL, Yang\u00a0GX, Leung\u00a0PSC, Gershwin\u00a0ME (2020) Cholangiocarcinoma in patients with Primary Sclerosing Cholangitis (PSC): a\u00a0comprehensive review. Clin Rev Allergy Immunol 58:134\u2013149. https:\/\/doi.org\/10.1007\/s12016-019-08764-7","journal-title":"Clin Rev Allergy Immunol"},{"key":"1197_CR27","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1572-0241.2006.00872.x","volume":"102","author":"JJW Tischendorf","year":"2007","unstructured":"Tischendorf\u00a0JJW, Hecker\u00a0H, Kr\u00fcger\u00a0M, Manns\u00a0MP, Meier\u00a0PN (2007) Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: A single center study. Am J Gastroenterol 102:107\u2013114. https:\/\/doi.org\/10.1111\/j.1572-0241.2006.00872.x","journal-title":"Am J Gastroenterol"},{"key":"1197_CR28","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1002\/hep4.1276","volume":"2","author":"B Torabi Sagvand","year":"2018","unstructured":"Torabi Sagvand\u00a0B, Edwards\u00a0K, Shen\u00a0B (2018) Frequency, risk factors, and outcome of gallbladder polyps in patients with primary sclerosing cholangitis: a case-control study. Hepatol Commun 2:1440\u20131445. https:\/\/doi.org\/10.1002\/hep4.1276","journal-title":"Hepatol Commun"},{"key":"1197_CR29","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1053\/j.gastro.2017.02.038","volume":"152","author":"TJ Weism\u00fcller","year":"2017","unstructured":"Weism\u00fcller\u00a0TJ, Strassburg\u00a0CP, Trivedi\u00a0PJ, Hirschfield\u00a0GM, Trivedi\u00a0PJ, Bergquist\u00a0A, Said\u00a0K, Imam\u00a0M, Lazaridis\u00a0KN, Juran\u00a0BD, Cheung\u00a0A, Lindor\u00a0KD, Weism\u00fcller\u00a0TJ, Lenzen\u00a0H, Manns\u00a0MP, Ponsioen\u00a0CY, Beuers\u00a0U, Holm\u00a0K, Naess\u00a0S, Karlsen\u00a0TH, Schrumpf\u00a0E, Boberg\u00a0KM, Gotthardt\u00a0D, Rupp\u00a0C, F\u00e4rkkil\u00e4\u00a0MA, Jokelainen\u00a0K, Marschall\u00a0HU, Benito de Valle\u00a0M, Thorburn\u00a0D, Saffioti\u00a0F, Weersma\u00a0RK, Fevery\u00a0J, Mueller\u00a0T, Chazouill\u00e8res\u00a0O, Schulze\u00a0K, Schramm\u00a0C, Almer\u00a0S, Pereira\u00a0SP, Levy\u00a0C, Mason\u00a0A, Bowlus\u00a0CL, Floreani\u00a0A, Halilbasic\u00a0E, Trauner\u00a0M, Yimam\u00a0KK, Milkiewicz\u00a0P, Milkiewicz\u00a0P, Huynh\u00a0DK, Pares\u00a0A, Manser\u00a0CN, Dalekos\u00a0GN, Eksteen\u00a0B, Invernizzi\u00a0P, Berg\u00a0CP, Kirchner\u00a0GI, Sarrazin\u00a0C, Zimmer\u00a0V, Fabris\u00a0L, Braun\u00a0F, Marzioni\u00a0M, Schramm\u00a0C, Chapman\u00a0RW, Chapman\u00a0RW, Lindor\u00a0KD, Imam\u00a0M, Lindor\u00a0KD, Naess\u00a0S, Karlsen\u00a0TH, Schrumpf\u00a0E, Boberg\u00a0KM, Hansen\u00a0BE, Hansen\u00a0BE, Hansen\u00a0BE (2017) Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis. Gastroenterology 152:1975\u20131984.e8. https:\/\/doi.org\/10.1053\/j.gastro.2017.02.038","journal-title":"Gastroenterology"}],"container-title":["Der Chirurg"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-020-01197-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00104-020-01197-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-020-01197-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T23:42:10Z","timestamp":1622590930000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00104-020-01197-5"}},"subtitle":["Erfahrungen aus 30\u00a0Jahren in einer monozentrischen Kohorte mit 173 konsekutiven Patienten"],"short-title":[],"issued":{"date-parts":[[2020,6,2]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["1197"],"URL":"https:\/\/doi.org\/10.1007\/s00104-020-01197-5","relation":{},"ISSN":["0009-4722","1433-0385"],"issn-type":[{"value":"0009-4722","type":"print"},{"value":"1433-0385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,2]]},"assertion":[{"value":"2 June 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"V.\u00a0Branchi, T.J.\u00a0Weism\u00fcller, T.\u00a0Zhou, J.\u00a0Henn, A.\u00a0Semaan, T.R.\u00a0Glowka, M.\u00a0Gonzalez-Carmona, C.\u00a0Strassburg, J.C.\u00a0Kalff, S.\u00a0Manekeller und H.\u00a0Matthaei geben an, dass kein Interessenkonflikt besteht. Die Arbeit wurde im Rahmen einer F\u00f6rderung durch das Else-Kr\u00f6ner-Forschungskolleg erstellt (VB).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Alle beschriebenen Untersuchungen am Menschen wurden im Einklang mit nationalem Recht sowie gem\u00e4\u00df der Deklaration von Helsinki von 1975 (in der aktuellen, \u00fcberarbeiteten Fassung) durchgef\u00fchrt. F\u00fcr retrospektive Studien dieser Art ist eine formelle Einverst\u00e4ndniserkl\u00e4rung bei anonymisiertem Gebrauch der Daten nicht notwendig.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}